36.18 -1.41 (-3.76%)
ABII
Stock Details
Last Trade:36.18 Change:-1.41 (-3.76%) Prev Close:37.59 Open: 37.50 Days Range:35.91 – 37.50 52 Week Range: 35.25 - 78.95 Volume:19858 P/E: N/AEPS:-7.59
View AllRecent Alerts 07/04/09
Recent Alert on 06/29/09 at 8:45am
Abraxis BioScience's (ABII) ABRAXANE Approved for Advanced Breast Cancer Patient Treatment in Quebec
Abraxis BioScience's (ABII) ABRAXANE Approved for Advanced Breast Cancer Patient Treatment in Quebec
Abraxis BioScience, Inc. (NASDAQ: ABII) announced the listing of ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) 100 mg in Quebec for the treatment of metastatic breast cancer with a... Read More
Recent Alert on 06/29/09 at 8:45am
Abraxis BioScience's (ABII) ABRAXANE Approved for Advanced Breast Cancer Patient Treatment in Quebec
Abraxis BioScience's (ABII) ABRAXANE Approved for Advanced Breast Cancer Patient Treatment in Quebec
Recent Alert on 06/18/09 at 3:29pm
Abraxis BioScience (ABII) Files $400M Mixed Shelf, Up To 2M Shares For Shareholders
Abraxis BioScience (ABII) Files $400M Mixed Shelf, Up To 2M Shares For Shareholders
Recent Alert on 06/01/09 at 1:12pm
Unusual 11 Mid-Day Movers 6/1: FEP, PMI, GPRE, ETWC Higher; ABIO, SNTA, ABII, EDZ Lower
Unusual 11 Mid-Day Movers 6/1: FEP, PMI, GPRE, ETWC Higher; ABIO, SNTA, ABII, EDZ Lower
Recent Alert on 06/01/09 at 8:29am
Abraxis BioScience (ABII) Announces Positive Data At ASCO on ABRAXANE
Abraxis BioScience (ABII) Announces Positive Data At ASCO on ABRAXANE
View AllRecent Press Releases
No Recent Press Releases Available